T1	Form 77 88	comprimidos
T2	CHEM 89 96	BIIB122
T3	DISO 150 173	enfermedad de Parkinson
#1	AnnotatorNotes T3	C0030567; Parkinson Disease; Disease or Syndrome
T4	LIVB 195 208	participantes
T6	Age 271 281	de 30 y 80
T7	DISO 325 348	Enfermedad de Parkinson
#2	AnnotatorNotes T7	C0030567; Parkinson Disease; Disease or Syndrome
T8	PROC 425 505	Estudio Fase 3, multicéntrico, aleatorizado, doble ciego, controlado con placebo
T9	PROC 511 545	determinar la eficacia y seguridad
T10	CHEM 549 556	BIIB122
T11	CHEM 557 563	DNL151
T12	LIVB 567 580	participantes
T13	DISO 585 608	Enfermedad de Parkinson
#3	AnnotatorNotes T13	C0030567; Parkinson Disease; Disease or Syndrome
T14	DISO 663 686	Enfermedad de Parkinson
#4	AnnotatorNotes T14	C0030567; Parkinson Disease; Disease or Syndrome
T15	PROC 751 770	Diagnóstico clínico
#5	AnnotatorNotes T15	C0332140; Diagnosis, clinical; Finding
T16	DISO 774 776	EP
#6	AnnotatorNotes T16	C0028797; Occupational Diseases; Disease or Syndrome | C0034065; Pulmonary Embolism; Pathologic Function | C1956257; Pulmonary Stenosis; Disease or Syndrome
T17	PROC 805 824	diagnóstico clínico
#7	AnnotatorNotes T17	C0332140; Diagnosis, clinical; Finding
T18	Duration 872 882	los 5 años
T19	PROC 899 918	visita de selección
T20	Age 939 955	al menos 30 años
T21	PROC 982 993	diagnóstico
#8	AnnotatorNotes T21	C0011900; Diagnosis; Diagnostic Procedure
T22	Neg_cue 1058 1069	ausencia de
T23	Negated 1070 1079	respuesta
T24	Neg_cue 1181 1192	ausencia de
T25	Negated 1193 1202	respuesta
T26	PROC 1249 1266	pruebas genéticas
#9	AnnotatorNotes T26	C0679560; Genetic screening method; Laboratory Procedure
T28	CHEM 1339 1379	cinasa rica en repeticiones de leucina 2
T29	DISO 1453 1474	Trastorno neurológico
#10	AnnotatorNotes T29	C0027765; nervous system disorder; Disease or Syndrome
T30	Neg_cue 1502 1513	distinto de
T31	DISO 1517 1519	EP
#11	AnnotatorNotes T31	C0028797; Occupational Diseases; Disease or Syndrome | C0034065; Pulmonary Embolism; Pathologic Function | C1956257; Pulmonary Stenosis; Disease or Syndrome
T32	Negated 1517 1519	EP
T33	DISO 1545 1570	accidente cerebrovascular
#12	AnnotatorNotes T33	C0038454; Cerebrovascular accident; Disease or Syndrome
T34	DISO 1572 1580	demencia
#13	AnnotatorNotes T34	C0497327; Dementia; Mental or Behavioral Dysfunction
T35	DISO 1583 1601	crisis epilépticas
#14	AnnotatorNotes T35	C0014544; Epilepsy; Disease or Syndrome | C4317109; Epileptic Seizures; Disease or Syndrome
T36	Duration 1606 1616	los 5 años
T37	PROC 1633 1652	visita de selección
T38	LIVB 1669 1681	investigador
#15	AnnotatorNotes T38	C0035173; Research Personnel; Professional or Occupational Group
T39	Spec_cue 1685 1693	Indicios
T40	DISO 1706 1727	parkinsonismo atípico
T41	Speculated 1706 1727	parkinsonismo atípico
T42	DISO 1737 1759	atrofia multisistémica
#16	AnnotatorNotes T42	C0393571; Multiple System Atrophy; Pathologic Function
T43	Speculated 1737 1759	atrofia multisistémica
T44	DISO 1762 1795	parálisis supranuclear progresiva
#17	AnnotatorNotes T44	C0038868; Progressive supranuclear palsy; Disease or Syndrome
T45	Speculated 1762 1795	parálisis supranuclear progresiva
T46	Spec_cue 1799 1810	indicios de
T47	Speculated 1811 1846	parkinsonismo inducido por fármacos
T48	DISO 1811 1824	parkinsonismo
#18	AnnotatorNotes T48	C0242422; Parkinsonian Disorders; Disease or Syndrome
T49	CHEM 1838 1846	fármacos
#19	AnnotatorNotes T49	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T51	PROC 1020 1052	escala modificada de Hoehn y Yah
T52	PROC 1167 1176	MDS-UPDRS
